Ekf Diagnostics, officially known as EKF Diagnostics Holdings plc, is a prominent player in the global diagnostics industry, headquartered in Great Britain. Founded in 2000, the company has established itself as a leader in point-of-care testing and laboratory diagnostics, with a strong operational presence across Europe, North America, and Asia. Specialising in innovative products such as blood glucose monitoring systems, haemoglobin analysers, and molecular diagnostics, EKF Diagnostics is recognised for its commitment to quality and accuracy. The company’s unique approach combines advanced technology with user-friendly designs, catering to the needs of healthcare professionals and patients alike. With a solid market position, EKF Diagnostics has achieved significant milestones, including strategic partnerships and a growing portfolio of patented technologies, solidifying its reputation as a trusted provider in the healthcare sector.
How does Ekf Diagnostics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Ekf Diagnostics's score of 24 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, EKF Diagnostics reported total carbon emissions of approximately 473,000 kg CO2e, with Scope 1 emissions at about 2,000 kg CO2e and Scope 2 emissions at around 374,000 kg CO2e. This marks a significant increase from 2022, when total emissions were approximately 338,000 kg CO2e, with Scope 1 emissions of about 21,000 kg CO2e. The company has not disclosed any Scope 3 emissions data, nor have they set specific reduction targets or initiatives as part of their climate commitments. Their emissions data indicates a reliance on mobile combustion, particularly noted in their Scope 1 emissions. As EKF Diagnostics continues to navigate its environmental impact, the absence of defined reduction targets suggests an opportunity for future commitments to enhance their sustainability efforts.
Access structured emissions data, company-specific emission factors, and source documents
2022 | 2023 | |
---|---|---|
Scope 1 | 1,000 | 0,000 |
Scope 2 | 12,000 | 000,000 |
Scope 3 | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ekf Diagnostics is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.